MOH — authorised 23 September 1997
- Marketing authorisation holder: HOSPIRA
- Status: likely_approved
🇮🇱 Corlopam in Israel
MOH authorised Corlopam on 23 September 1997
Marketing authorisation
Corlopam in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Cardiovascular approved in Israel
Frequently asked questions
Is Corlopam approved in Israel?
Yes. MOH authorised it on 23 September 1997.
Who is the marketing authorisation holder for Corlopam in Israel?
HOSPIRA holds the Israeli marketing authorisation.